VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group — Konstantinos Zervas (2007) | RDL Network
VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group
Konstantinos Zervas, Meletios A Dimopoulos, E Hatzicharissi, Αchilles Anagnostopoulos, Mary Papaioannou, C. Mitsouli, P. Panagiotidis, John Korantzis, M. Tzilianos, Alice Maniatis
Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva, Meletios A Dimopoulos, Ofer Shpilberg, Martin Kropff, Ivan Špıčka, Maria Teresa Petrucci, Antonio Palumbo, Olga Samoilova, Anna Dmoszyńska, Abdulkadyrov Km, Rik Schots, Bin Jiang, María-Victoria Mateos, Kenneth C. Anderson, Dixie Esseltine, Kevin Liu, Andrew Cakana, Helgi van de Velde, Paul G. Richardson
Discussion(0)
No comments yet. Be the first to comment.